Gossamer Market Capitalization from 2010 to 2024
| GOSS Stock | USD 0.70 0.01 1.41% |
Check Gossamer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gossamer Bio's main balance sheet or income statement drivers, such as Interest Income of 1.5 M, Interest Expense of 8.2 M or Selling General Administrative of 36.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.33. Gossamer financial statements analysis is a perfect complement when working with Gossamer Bio Valuation or Volatility modules.
Gossamer | Market Capitalization |
Latest Gossamer Bio's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Gossamer Bio over the last few years. It is Gossamer Bio's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gossamer Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 159.01 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Gossamer Market Capitalization Regression Statistics
| Arithmetic Mean | 497,804,054 | |
| Geometric Mean | 425,639,948 | |
| Coefficient Of Variation | 53.76 | |
| Mean Deviation | 194,260,921 | |
| Median | 445,473,630 | |
| Standard Deviation | 267,620,872 | |
| Sample Variance | 71620.9T | |
| Range | 951.3M | |
| R-Value | (0.1) | |
| Mean Square Error | 76404.2T | |
| R-Squared | 0.01 | |
| Significance | 0.73 | |
| Slope | (5,806,084) | |
| Total Sum of Squares | 1002693T |
Gossamer Market Capitalization History
About Gossamer Bio Financial Statements
Gossamer Bio shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Gossamer Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Gossamer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Gossamer Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Gossamer Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 185 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.